Hongbing Wang, associate professor, Department of Physiology Neuroscience Program, received his bachelor's degree in cell biology from Peking University. During doctoral study at UCLA and post-doc training at University of Washington, he had the opportunity to interact with neuroscientists of various backgrounds, and started to appreciate the power of cellular and animal models that may aid the development of therapies for neurological disorders.
His lab at MSU investigates the cellular and molecular mechanisms underlying synaptic modification and certain aspects of adaptive behavior. By using molecular and cellular, transgenic, electrophysiological, and behavioral approaches, the lab recently identified potential therapeutic targets for autism, Fragile X mental retardation, schizophrenia, and bipolar disease. They are now validating the therapeutic values of these targets as well as developing potential therapies.